We observed that high LINC00052 expression is associated with increased survival in patients with luminal A, ER+, PR+ and TNBC breast cancer, data consistent with previous reports that showed that high LINC00052 expression is associated with greater overall survival in BC patients [15,20]. This evidence concerns the gene LINC00052 and breast carcinoma.